Platform
Features
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Employees
Links
Kenneth Galbraith
53 members
18 members
6 members
14 members
9 members
View all
Neuralink
60 followers
Cytokinetics
11 followers
CRISPR Therapeutics
10 followers
ONI
6 followers
Arvinas
3 followers
Axsome Therapeutics
BridgeBio
Cerus
Centogene
ImmunityBio
MeiraGTx
1 follower
Explore companies